Earning Aug 7th, this to keep track of the stock for my own study to see if this works out. This is not for trading, just learning patterns
Dagangan aktif
Consensus analyst price targets for Q2–Q3 2025:• The average 12‑month target for CNQ is around C$54.42, with forecasts ranging from C$46 to C$63   .
• Recent analyst updates:
• Scotiabank raised its target to C$54 (from C$50), rating the company as Outperform .
• Wells Fargo lifted its target to C$46 (from C$42), setting an Equal Weight rating .
• Desjardins, Raymond James, and Evercore ISI have all reaffirmed Buy or Outperform stances with targets in the C$49–56 band  .
Projected Q2 2025 EPS:
• Zacks Research recently adjusted its Q2 earnings estimate to C$0.59 per share, down from an earlier C$0.68 estimation—suggesting weaker quarter‐on‐quarter performance .
• By comparison, Q1 2025 EPS came in at around C$0.65, a slight miss versus consensus .
⸻
🎯 Where Might the Stock Head in Q2 2025?
In Canadian Dollars (TSX: CNQ.TO)
Analyst consensus leans toward a fair value near C$54, and current trading around C$43–44 CAD implies potential upside of 20–25% over the next 6–12 months. Although EPS guidance has been slightly adjusted downward for Q2, price targets remain resilient at C$46–56 from a majority of analysts   .
Given that consensus targets are for 12‑month horizons (i.e. extending through full fiscal 2025), one can infer that by the end of Q2 or into the following quarter, price may slowly drift upward within that range—possibly approaching C$46–50 by late Q2 or early Q3, if earnings and oil/gas conditions remain stable.
In U.S. Dollars (NYSE: CNQ)
If converted at current exchange rates (~1.36 CAD/USD):
• A C$54 target → USD ~$40
• A C$46 low → USD ~$34
• A C$63 high → USD ~$46.50
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.